Egypt went from 7 licensed supplement factories to 41. Here is what changed.

In 2020, Egypt had seven factories licensed to manufacture dietary supplements. By late 2024 it had 34, and by 2025 the count had reached 41. That is not a market growing — that is a market being built.

If you are a brand owner deciding where to manufacture, or a distributor deciding whether an Egyptian supplier is a safe bet, the number matters less than the mechanism behind it. Here is what actually changed.

The White List is the whole story

The shift traces back to one institution: the National Food Safety Authority (NFSA), and specifically its White List of approved manufacturing facilities.

Before the NFSA, supplement manufacturing in Egypt was fragmented and lightly supervised. The White List changed the terms. A facility on it has been inspected and approved to manufacture dietary supplements, and products made outside it face a much harder path to registration and to export documentation.

The result was a filter, not a floodgate. Factories that could meet the standard invested and got listed. Factories that could not, did not. Going from 7 to 41 in five years means the barrier was real enough to be meaningful and achievable enough to be worth clearing.

Dr. Mohamed Anwar, who chairs Organix and serves as President of the Egyptian Association of Food and Dietary Supplement Manufacturers and Exporters, put the before-and-after plainly in 2024: 34 licensed factories, against seven in 2020. By 2025 he was citing 41.

Worth knowing for context: the NFSA itself was established in 2017, with its executive regulation issued in January 2018. The factory count did not start moving until the regulator existed to move it.

Around 40 factories, roughly 4,000 brands

Here is the number that surprises people: as of 2024, those factories were manufacturing for approximately 4,000 companies.

That ratio — roughly 100-plus brands per factory — tells you the structure of the industry. Egypt's supplement market is overwhelmingly contract manufacturing. The brand on the pack and the facility that made it are almost never the same organisation.

This is normal. It is how most of the global supplement industry works, and it is not a quality signal in either direction on its own. What it does mean is that choosing a brand to buy, and choosing a factory to manufacture with, are two completely different decisions — and that the second one is where quality is actually determined.

What the market looks like

Three figures frame the opportunity:

• Egypt's domestic supplement market passed EGP 10 billion.
• The wider Middle East and Africa supplement market recorded more than USD 3.5 billion in 2023.
• Registered supplements in Egypt went from over 11,000 notifications in 2024 to more than 12,000 by 2025 — of which, by Dr. Anwar's estimate, roughly half are actually marketed.

The pandemic is the usual explanation for the demand side, and it is partly right — immunity-focused products pulled a lot of first-time buyers into the category. Sports nutrition did the rest.

But demand alone does not build factories. What made Egypt a manufacturing base rather than just a consumer market was the combination of demand, a regulatory framework that made compliance legible, and a cost structure that works for export.

What this means if you are sourcing

If you are evaluating an Egyptian contract manufacturer, the White List is your floor, not your ceiling. Every serious candidate will be on it. The differences live above that line:

Certification depth. ISO 9001 covers quality management, ISO 22000 and FSSC 22000 cover food safety, ISO 45001 covers worker safety, and GMP covers manufacturing practice. A facility holding all of them has built a system, not collected badges. Ask which GMP classification — pharmaceutical-grade classifications such as Class D impose tighter environmental control than a general food GMP.

Dosage form range. A factory that runs tablets and capsules only will quote you confidently and then struggle when your second product is a liquid sachet. Range matters because product lines grow.

Export track record. Registration requirements differ sharply by destination. A manufacturer that has already shipped into your target market has solved paperwork you would otherwise be discovering for the first time.

Who else they manufacture for. Egyptian law requires the manufacturing facility's name on the pack. That means a factory's client list is, by law, partly public — walk a pharmacy aisle and read the backs of the packs.

Where Organix sits

We were licensed and began production in 2020, at the start of this shift rather than after it.

Today the facility holds ISO 9001:2018, ISO 22000:2018, ISO 45001:2018, FSSC 22000, GMP at Class D Pharmaceutical classification, NFSA White List approval and the Egypt Seal of Quality. We manufacture across 13 dosage forms with capacity of up to 3 million units per month, have produced more than 1,500 formulas and products for over 500 companies, and have exported to 11 countries.

The most recent addition is an effervescent department — effervescent tablets and effervescent powder sachets — which we did not have the capability to produce before.

The honest caveat

A growing factory count is good for buyers, but it is not a guarantee. Around forty approved facilities is still a small number for a market serving 4,000 brands, and capacity is tight across the sector. Egypt's manufacturers are, as a rule, busy.

That has a practical consequence worth saying out loud: lead times in this market run longer than brand owners expect. Our own chairman has said so publicly, and apologised to clients for delays, in more than one interview. We would rather you heard it from us than discovered it.

Ask any Egyptian manufacturer for a realistic date rather than an optimistic one, and treat a suspiciously short quote as a question rather than a win.

The other constraint is registration speed, and it is not the factories' to fix. One of our clients in Sierra Leone spent five months in Egypt waiting for a product registration to clear. During those five months, he sent us photographs of a container of the same product, manufactured in Turkey and already shipped. Manufacturing capability is not Egypt's bottleneck. Paperwork turnaround still is.